The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

被引：16

作者：

Higgins, Peter D. R. ^{[1
]}

Ng, Siew ^{[2
]}

Danese, Silvio ^{[3
]}

Rao, Krishna ^{[1
]}

机构：

[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA

[2] Chinese Univ Hong Kong, Dept Internal Med, Hong Kong, Peoples R China

[3] Humanitas Univ, Dept Internal Med, Milan, Italy

来源：

CROHNS & COLITIS 360 | 2020年 / 2卷 / 02期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1093/crocol/otaa026

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.

引用

页数：4

共 4 条

[1]

[Anonymous], 2020, IOIBD UPDATE COVID19

[2] Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease [J].

Cullen, Garret ;

Bader, Caroline ;

Korzenik, Joshua R. ;

Sands, Bruce E. .

GUT, 2012, 61 (03) :385-391

[3] Is Crohn's Disease the Price to Pay Today for Having Survived the Black Death? [J].

Dumay, Anne ;

Gergaud, Olivier ;

Roy, Maryline ;

Hugot, Jean-Pierre .

JOURNAL OF CROHNS & COLITIS, 2019, 13 (10) :1318-1322

[4] Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease [J].

Torres, Joana ;

Boyapati, Ray K. ;

Kennedy, Nicholas ;

Louis, Edouard ;

Colombel, Jean-Frederic ;

Satsangi, Jack .

GASTROENTEROLOGY, 2015, 149 (07) :1-15

← 1 →